TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 37 filers reported holding TREVI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 43.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,021,765 | -4.5% | 927,415 | +4.7% | 0.61% | -6.4% |
Q2 2023 | $2,117,358 | +29.2% | 885,924 | 0.0% | 0.66% | -3.2% |
Q1 2023 | $1,638,959 | +10.6% | 885,924 | +15.4% | 0.68% | +59.7% |
Q4 2022 | $1,481,528 | +2.5% | 767,631 | -18.3% | 0.42% | -13.3% |
Q3 2022 | $1,446,000 | – | 939,265 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 1,263,408 | $2,843,000 | 0.32% |
NEA Management Company, LLC | 5,940,796 | $13,367,000 | 0.17% |
TPG Group Holdings (SBS) Advisors, Inc. | 4,824,883 | $10,856,000 | 0.08% |
WealthTrust Axiom LLC | 39,500 | $88,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 34,600 | $78,000 | 0.00% |
BlackRock Inc. | 44,180 | $99,000 | 0.00% |
LPL Financial LLC | 10,000 | $23,000 | 0.00% |
Alberta Investment Management Corp | 25,000 | $56,000 | 0.00% |
Tower Research Capital LLC (TRC) | 4,187 | $10,000 | 0.00% |
Renaissance Technologies | 92,600 | $208,000 | 0.00% |